Jean‐Luc Berger

740 total citations
16 papers, 345 citations indexed

About

Jean‐Luc Berger is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Jean‐Luc Berger has authored 16 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Jean‐Luc Berger's work include HIV Research and Treatment (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Parvovirus B19 Infection Studies (2 papers). Jean‐Luc Berger is often cited by papers focused on HIV Research and Treatment (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Parvovirus B19 Infection Studies (2 papers). Jean‐Luc Berger collaborates with scholars based in France, Canada and United States. Jean‐Luc Berger's co-authors include Serge Renaud, Jean-Claude Ruf, Byong H. Lee, Christophe Lacroix, Denis Roy, G. Reuter, Anne‐Marie Bouvier, Caroline Dupont, Pierre Tattevin and Sophie Grabar and has published in prestigious journals such as Clinical Infectious Diseases, Arteriosclerosis Thrombosis and Vascular Biology and International Journal of Cancer.

In The Last Decade

Jean‐Luc Berger

15 papers receiving 328 citations

Peers

Countries citing papers authored by Jean‐Luc Berger

Since Specialization

Citations

This map shows the geographic impact of Jean‐Luc Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Luc Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Luc Berger more than expected).

Fields of papers citing papers by Jean‐Luc Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Luc Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Luc Berger. The network helps show where Jean‐Luc Berger may publish in the future.

Co-authorship network of co-authors of Jean‐Luc Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Luc Berger. A scholar is included among the top collaborators of Jean‐Luc Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Luc Berger. Jean‐Luc Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller 2023 ·Cell Host & Microbe ·(unknown), Eduard Baquero, (unknown), Valérie Lorin, Caroline Charre, Cyril Planchais, Jordan D. Dimitrov, Valérie Monceaux, Matthijn Vos, Laurent Hocqueloux, Jean‐Luc Berger, Michael S. Seaman, Martine Braibant, Véronique Avettand-Fènoël, Asier Sáez‐Cirión, Hugo Mouquet	9
2	Persistently elevated alkaline phosphatase could be related to Paget’s disease of bone in a patient receiving tenofovir disoproxil fumarate 2022 ·International Journal of STD & AIDS ·(unknown), Jean‐Luc Berger, (unknown), Yohan N’Guyen, Firouzé Bani‐Sadr	0
3	Single-Dose 13-Valent Conjugate Pneumococcal Vaccine in People Living With HIV – Immunological Response and Protection 2021 ·Frontiers in Immunology ·(unknown), Mathilde Bahuaud, (unknown), Maxime Hentzien, Jean‐Luc Berger, A. Robbins, Delphine Lebrun, Yohan N’Guyen, Firouzé Bani‐Sadr, Frédéric Batteux, Amélie Servettaz	4
4	Early Neuropsychological Adverse Events after Switching from PI/r to Dolutegravir Could be Related to Hyperthyroidism in Patients under Levothyroxine 2016 ·Antiviral Therapy ·Jean‐Luc Berger, Yohan N’Guyen, Delphine Lebrun, (unknown), Maxime Hentzien, Hélène Marty, Firouzé Bani‐Sadr	2
5	Trends in survival after cancer diagnosis among HIV‐infected individuals between 1992 and 2009. Results from the FHDH‐ANRSCO4 cohort 2015 ·International Journal of Cancer ·Mira Hleyhel, Aurélien Belot, Anne‐Marie Bouvier, Pierre Tattevin, Jérôme Pacanowski, Philippe Genet, Nathalie De Castro, Jean‐Luc Berger, Caroline Dupont, A. Lavolé, Christian Pradier, Dominique Salmon‐Céron, Anne Simon, Valérie Martinez, Jean‐Philippe Spano, Dominique Costagliola, Sophie Grabar, (unknown)	34
6	Risk of AIDS-Defining Cancers Among HIV-1–Infected Patients in France Between 1992 and 2009: Results From the FHDH-ANRS CO4 Cohort 2013 ·Clinical Infectious Diseases ·Mira Hleyhel, Aurélien Belot, Anne‐Marie Bouvier, Pierre Tattevin, Jérôme Pacanowski, Philippe Genet, Nathalie De Castro, Jean‐Luc Berger, Caroline Dupont, A. Lavolé, Christian Pradier, Dominique Salmon‐Céron, Anne Simon, Valérie Martinez, Dominique Costagliola, Sophie Grabar	73
7	Utilisation de produits oenologiques et analyse des risques pour le consommateur 2005 ·(unknown), Jean‐Luc Berger	1
8	Évolution de la contamination en Ochratoxine A : Du vignoble français au vin 2004 ·(unknown), Laurence Guérin, (unknown), (unknown), Jean‐Luc Berger, (unknown)	3
9	Osteonecrosis in Six HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy 2004 ·Annals of Pharmacotherapy ·(unknown), C. Strady, (unknown), I. Béguinot, Jean‐Luc Berger, Thierry Trenque	22
10	Creation clonale dirigee par embryogenese somatique 2002 ·Dialnet (Universidad de la Rioja) ·(unknown), Jean‐Luc Berger, Roger Bessis	1
11	Mejoras y correcciones de la materia prima 2000 ·Dialnet (Universidad de la Rioja) ·(unknown), Jean‐Luc Berger, Jacques Blouin, Pierre Dupuy	1
12	Aide a la conduite des pressoirs a membrane par capteurs qualitatives 1998 ·Dialnet (Universidad de la Rioja) ·Jean‐Luc Berger, (unknown), (unknown), (unknown), (unknown)	1
13	Purification of Glucoamylase from Lactobacillus amylovorus ATCC 33621 1997 ·Current Microbiology ·(unknown), Jean‐Luc Berger	20
14	Purification, properties and characterization of a high‐molecular‐mass b‐galactosidase isoenzyme from Thermusaquaticus YT‐I 1997 ·Biotechnology and Applied Biochemistry ·Jean‐Luc Berger, Byong H. Lee, Christophe Lacroix	39
15	Platelet Rebound Effect of Alcohol Withdrawal and Wine Drinking in Rats 1995 ·Arteriosclerosis Thrombosis and Vascular Biology ·Jean-Claude Ruf, Jean‐Luc Berger, Serge Renaud	112
16	Characterization of dairy-related Bifidobacterium spp. based on their β-galactosidase electrophoretic patterns 1994 ·International Journal of Food Microbiology ·Denis Roy, Jean‐Luc Berger, G. Reuter	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact